Alimera Sciences, Inc. Discusses Its 2021 Global Expansion Strategy with The Stock Day Podcast

Feb 01, 2021, 01:51 PM

The Stock Day Podcast welcomed Alimera Sciences, Inc. (ALIM)(“the Company”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. President and CEO of the Company, Rick Eiswirth, joined Stock Day host Everett Jolly. 
Subscribe
Next
Global Trac Solutions Discusses The Conscious Fund Investment and JV Partnership with PsychDev Inc. On The Stock Day Podcast
Top episodes